Although the healthcare industry is undergoing rapid change, marketing approaches are evolving in fits and starts. Learn more in the 2016 Healthcare Marketers Trend Report.
"Globally, you're seeing a lot more unbranded campaigns," he explains.
ConvergeHEALTH by Deloitte has entered into a multi-year collaboration with Forest Labs and Intermountain Healthcare to conduct outcomes research.
The pharma market research major is working on unifying into one company with two main product lines, and is also in the process of a re-brand.
The Affordable Care Act has spurred double-digit increases in demand for pharmaceuticals, new data suggest.
IMS Health raised $1.3 billion last month in its New York IPO.
Researchers have developed and tested a checklist that aims to evaluate comparative effectiveness research and distinguish real-world studies that are good enough for decision-making about treatments.
Merck has broadened its analytics approach to include team-ups with a slate of organizations at the intersection of Big Data and health IT.
National Pharmaceutical Council (NPC) said Eli Lilly joined earlier this year
Suppliers are touting a deeper level of analysis, in some cases bypassing the market-research function and reaching the highest levels of their pharma clients.
The data and analytics giant is looking to launch an IPO. The company, which is the subject of an antitrust suit, said in its prospectus that it anticipates future acquisitions.
The regulator's proposed database could help identify adverse events.
IMS Health brought market access firm HGS Europe into the fold last month.
When an FDA advisory panel met last month to vote on whether to recommend approval of Sanofi's MS drug Lemtrada, patient opinion leaders had already voiced their view.
The Centers for Medicare and Medicaid Services (CMS) unveiled a new research tool last month.
Eli Lilly is tapping Humana's claims database for therapeutic study
The American College of Cardiology (ACC) said it's entered an agreement to cull insights from a healthcare database
The first on-demand way to tap the influencer community in healthcare went live today, and results of a real-world test show it has the potential to accelerate the research process.
The partnership seeks to improve medication adherence through predictive analytics.
Symphony Health Solutions filed an antitrust lawsuit against IMS Health, accusing it of trying to monopolize the pharma data and analytics market
The NIH said it will fund up to $24 million per year for four years to establish six to eight Big Data to Knowledge (BD2K) Centers of Excellence
Private equity firm Symphony Technology Group acquired several divisions of United BioSource Corp.
Memoto's tiny clip-on camera provides a detailed timeline of a patient's daily activities
A study, offers for the first time, according to researchers, empirical evidence of the link between a company's culture from a commercial-operations standpoint and revenue performance.
Double-digit growth and a fragmented healthcare system in India have spurred consultancies and data firms, although experts say pricing for services varies widely.
Athenahealth has wasted little time in putting its mark on Epocrates
Fiscal concerns are paramount in the rise of Big Data within healthcare, according to a recent McKinsey analysis, but clinical trends also play a role
Healthcare data and analytics giant IMS Health bought Seattle-based software-as-a-service (SaaS) company Appature.
New York University is forming a Center for Data Science, plus a master's-level degree program to prepare the next generation of data professionals
"The marketing research community should be very satisfied with the additional guidance on the Sunshine Act from CMS," said the PMRG's government affairs committee chair
GSK Consumer Health Care is the newest member of a research organization that conducts experiments into how shoppers think and behave.
Pfizer and clinical data outfit Humedica jointly announced their intent to collaborate on studies examining the effectiveness of treatments.
Frank Lavelle officially became CEO of data and analytics provider Symphony Health Solutions in mid-January.
PatientsLikeMe, the online patient network and research platform, appointed Daphne Psacharopoulos to the new position of VP, client services and strategic initiatives
Law firm Morrison & Foerster launched a that indexes average up-front payments in agreements between biotech companies and companies that pay for commercialization rights.
Bristol-Myers Squibb is laying off close to 100 employees, including market researchers, as it recovers from patent expiries and awaits new approvals.
Pharma marketing researchers should provide actionable recommendations to brand managers and be more proactive in identifying opportunities to research business issues, said TGaS Advisors.
Life science firms are starting to realize that most of the innovation unleashed by Big Data will happen through incremental, bottom-up changes rather than the top-down kind.
Software-as-a-service (SaaS) provider Appature has signed up several healthcare marketing agencies to use its cloud-based relationship marketing tool.
Budgets of pharmaceutical marketing research teams are starting to recover, one analyst firm found.
Healthcare marketing research firm WorldOne expanded its board of directors with the addition of Kerry Hicks, the founder and former CEO of HealthGrades
IMS Health acquired TTC, a Philadelphia-based trial benchmarking and analytics firm
CarbonSix said it launched a tool that can deliver "in the moment" insight about patients living with chronic medical conditions.
Healthcare data firm WorldOne has acquired Sermo
EvaluatePharma named Debbie Paul to the position of CEO Americas, EvaluatePharma USA
Symphony Technology Group, a private equity firm, acquired the healthcare analytics business of Wolters Kluwer, the companies said.
Private-equity firm Veritas Capital will buy the healthcare business of Thomson Reuters for $1.25 billion in cash.
Genentech is thinking outside the traditional focus group to better understand patients which, in turn, is helping address adherence and brand preference.
Biopharma consultancy Campbell Alliance launched a market research and analytics group, one that could pose a threat to traditional MR firms.
- Guidemark Health merges with three companies to form new agency
- Five things for pharma marketers to know: Monday, October 17, 2016
- Five things for pharma marketers to know: Thursday, October 20, 2016
- Five things for pharma marketers to know: Friday, October 14, 2016
- Five things for pharma marketers to know: Tuesday, October 18, 2016
- Merck educates doctors about biosimilars, long before it will sell one in the U.S.
- 4 trends with the potential to change behavior in the patient journey
- 2016 Pharma Report: All the data in one place
- What do physicians think about biosimilars?
- Novartis considers new sales model for experimental cancer therapy
- Five things for pharma marketers to know: Friday, October 21, 2016
- Trump or Clinton? Either May Lead to Better Mental Healthcare
- Five things for pharma marketers to know: Thursday, October 20, 2016
- Why Excedrin embraced the headache of a contentious election season
- StartUp Health reports more global deals, uptick in pharma investment in digital health